Executive Leadership Team

The Executive Leadership Team translates strategy and policy into outcomes-based plans, in collaboration with the Board of Directors, ultimately advancing DIA’s impact across the globe.

Barbara Lopez Kunz

Global Chief Executive

Send Email

  
Barbara Lopez Kunz serves as President and Global Chief Executive of DIA, driving thought leadership and innovation in therapeutic development to improve the health of people worldwide. She previously served as President of Health and Life Sciences at Battelle, one of the world’s largest, most respected R&D organizations. She has also served as Senior Vice President/General Manager for Thermo Fisher Scientific’s Biosciences Division, as SVP for DuPont, and head of R&D for ICI. A dedicated volunteer for children's health, Barbara chairs the board of Children's National Research Institute, serves as advisor to the UC I4H Fellowship, and as Director for Aptevo Therapeutics.

Jack Foster

Chief Financial Officer

Send Email

  
Jack has over 25 years’ experience in the Life Sciences industry. He began his career with Wyeth International where he supported the growth of Wyeth’s developing markets in Europe, the Middle East and Africa. Following Wyeth, Jack held a senior finance role with Auxilium Pharmaceuticals until its acquisition by Endo Pharmaceuticals in 2015. Jack then joined InClinica, Inc., a boutique CRO, in 2016 and was CFO until its liquidation in 2020. Jack has recently consulted for multiple development-phase companies in the Biotech & Instrument spaces. Mr. Foster holds a Bachelor of Arts in Finance from Temple University and a Master of Business Administration degree from Villanova University.

Timothy Hess

Vice President of IT

Send Email

  
Timothy Hess serves as Vice President of IT, responsible for DIA’s global IT operations, computer infrastructure, customer and membership management databases, and website. He previously served as Director of Business Technology for Thomas Publishing Company LLC, where he managed all internal business systems, production systems, and technology projects; and as Vice President &Chief Technology Officer for Content Data Solutions, Inc., and as R&D Director for Reed Technology & Information Services. A proven technology thought leader with extensive experience in delivering high-performance systems that solve complex business problems in all development environments, Mr. Hess earned his computer science degree from Arcadia University.

Katie Hill

Vice President, Learning and Digital Solutions

Send Email

  
Katie serves as Vice President, Learning and Digital Solutions, and is responsible for global development and implementation of DIA’s Learning and digital product strategy, including membership, DIA NOW and other digital solutions. Katie joined DIA in 2003 and has served in successively broader roles in training, volunteer services and program development, and managed DIA’s extensive portfolio of instructor-led and online courses. Prior to DIA, Katie served as Legislative Aide to Texas Senator Steve Ogden, as an assistant in the US FDA Office of Policy, and as a high school history teacher. Katie earned her BA in History and Masters’ Degree in Secondary Education from Trinity University.

Courtney Granville

Global Associate Director, Research and Scientific Programs

Send Email

  
As Global Associate Director Research & Scientific Programs, Dr. Granville provides insight, guidance, and a collaborative approach to build DIA’s research and thought leadership to support innovation and building efficiency in drug, device and diagnostics development. She brings 2 decades of regulatory science-related research experience to her role at DIA. Her research career focused on developing data to support regulatory decision making in the fields of tobacco regulatory science, preclinical and molecular toxicology, nonclinical drug development, and public health. She has worked in academic, government, and industry laboratories leading both clinical and non-clinical research studies, assuring IRB and GLP compliance where relevant.

Anna McDermott-Vitak

Senior Vice President & Managing Director, DIA Americas

Send Email

  
Anna serves as Senior Vice President & Managing Director, DIA Americas, leading implementation of DIA’s strategic initiatives, centered on advancing thought leadership across the therapeutic development continuum, and member programs in the Americas. She previously served as SVP, Business Development & Administration at the Association for Accessible Medicines. She also served as ED at Amgen. Her career at Amgen spanned almost two decades, with roles in project management, clinical studies management team leader, investor relations and government affairs. Anna has a BA in Biology, and an MBA in Marketing, both from LaSalle University. She serves on the board of the Catholic Coalition for Special Education.

Ania Mitan

Senior Vice President & Managing Director, DIA EMEA, India and Singapore

Send Email

  
Ania Mitan serves as the Senior Vice President & Managing Director, DIA EMEA, India and Singapore. She is former Executive Director of the commercial organization at Celgene, where she built the oncology business in the EMEA region with healthcare partners to shape quality delivery systems and new commercialization models in personalized medicine, specifically with novel cell and gene therapies. She began her career at Eli Lilly and Company, serving as Head of Commercial Development for EU mid-size countries, Head of Primary Care Business Unit for the UK and Ireland, and Head of Marketing for the Critical Care Unit. Ania earned her MBA from Simmons College and MSc in Pharmacy from Silesian Medical Academy (Poland).

Hajime Saijo

Senior Vice President & Managing Director, DIA Japan

Send Email

  
Hajime “Jim” Saijo, PhD, MBA, is the Sr. VP, managing director of DIA Japan. He previously established and lead the Academia Clinical Research Division, CMIC K.K., as Corporate Officer managing clinical research and investigator sponsored clinical trials. Dr. Saijo’s experience also includes serving as Director of R&D for Alcon Japan; Director of R&D and Representative Director for start-up operations of Ferring Pharmaceuticals Co. Ltd.; and as VP of Medical, Clinical and Regulatory Affairs for Japan & APEC for OvaScience. Dr. Saijo earned his PhD in Medical Science from Tokyo Medical and Dental University Graduate School of Medicine and Dentistry, and his MBA in Business Administration from Temple University Business School, Japan Campus.

Katie Truong

Director, People Operations

Send Email

  
Katie Truong serves as the head of People Operations, leading DIA’s global People strategy and talent initiatives to further DIA’s purpose and vision. She is focused on building a high-performance mission-driven culture that embraces diversity, equity, inclusion, and belonging. Katie brings experience from diverse industries such as government and professional services. Just before joining DIA, Katie worked for a renowned global design firm. Katie earned her Bachelor of Arts degree from the University of Virginia and is pursuing her Master in Business Administration from New York University Stern School of Business, specializing in leadership and strategy.

Tong-Yan Wang

Senior Vice President & Managing Director, DIA China

Send Email

  
Tong-Yan brings 20+ years of experience in the pharmaceutical industry with a track record of business leadership and development, engagement with stakeholders across industry and government, and volunteer leadership experience in non-profit associations. She joins DIA after spending 4 years as the CEO of Sanpower Group to build up its healthcare business. Before Sanpower, she worked in Xi’an Janssen in various roles under General Med, Specialty Rx, and Market Access & Government Affairs. Tong-Yan started her career as a professor at Xian Medical University after receiving her Bachelor of Medical Science degree. She earned her MBA from Xian Jiao Tong University and her PhD in Management from ISCTE in Lisbon, Portugal.